176237-44-8 Usage
Uses
Used in Pharmaceutical Research:
L-Norvaline, 5-hydroxy-N-[(phenylmethoxy)carbonyl]-, 1-methylethyl ester is used as a research compound for its potential anti-cancer properties. It has shown promise in inhibiting the production of enzymes that are associated with cancer cell growth, making it a valuable tool in the development of new cancer treatments.
Used in Neuroprotection:
L-Norvaline, 5-hydroxy-N-[(phenylmethoxy)carbonyl]-, 1-methylethyl ester is used as a neuroprotective agent due to its potential to protect neurons from damage and degeneration. This property makes it a promising candidate for the development of treatments for neurodegenerative diseases.
Used in Immunomodulation:
L-Norvaline, 5-hydroxy-N-[(phenylmethoxy)carbonyl]-, 1-methylethyl ester is used as an immunomodulatory agent for its ability to modulate the immune response and reduce inflammation. This makes it a potential candidate for the development of treatments for inflammatory conditions and autoimmune diseases.
Used in Chemical Synthesis:
L-Norvaline, 5-hydroxy-N-[(phenylmethoxy)carbonyl]-, 1-methylethyl ester is used as a chemical intermediate in the synthesis of other compounds with potential therapeutic applications. Its enhanced solubility in organic solvents makes it a valuable component in various chemical reactions and processes.
Check Digit Verification of cas no
The CAS Registry Mumber 176237-44-8 includes 9 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 6 digits, 1,7,6,2,3 and 7 respectively; the second part has 2 digits, 4 and 4 respectively.
Calculate Digit Verification of CAS Registry Number 176237-44:
(8*1)+(7*7)+(6*6)+(5*2)+(4*3)+(3*7)+(2*4)+(1*4)=148
148 % 10 = 8
So 176237-44-8 is a valid CAS Registry Number.
InChI:InChI=1/C16H23NO5/c1-12(2)22-15(19)14(9-6-10-18)17-16(20)21-11-13-7-4-3-5-8-13/h3-5,7-8,12,14,18H,6,9-11H2,1-2H3,(H,17,20)/t14-/m0/s1
176237-44-8Relevant academic research and scientific papers
Enantioselective syntheses of (R)- and (S)-hexahydropyridazine-3-carboxylic acid derivatives
Schmidt, Ulrich,Braun, Christine,Sutoris, Heinz
, p. 223 - 229 (2007/10/03)
Appropriately protected optically active tetrahydropyridazine-3-carboxylic acid and hexahydropyridazine-3-carboxylic acid were prepared via ring closure of α-hydrazino- and δ-hydrazinopentanoates. Either optically active glutamic acid or an enantioselective catalytic hydrogenation was used to generate the chiral center. The numerous optically active intermediates are valuable starting materials for the synthesis of other unusual amino acids.
